Heidi Christine Courchane, APRN

Heidi Courchane practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Heidi Courchane's NPI, 1053017723, was assigned on February 6, 2023. Heidi Courchane holds Florida license 11020284.

Heidi Courchane's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Heidi Courchane also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Heidi Courchane's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Heidi Courchane to 2 more group practices and clinics, 1 breast imaging center, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Heidi Courchane practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Heidi Courchane's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Heidi Courchane is licensed in Florida.

CMS data shows 37 Medicare services from Heidi Courchane across 1 procedure code in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $2,577 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Heidi Courchane in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Heidi Courchane's median patient age at 63, with 98% women.

In 2024, Heidi Courchane wrote 111 Medicare Part D claims for 53 patients. 97% of them were for generic drugs. CMS names the drug for 70 of them, across 2 drugs with 11 or more claims each, at $1,877 in total drug cost.

Heidi Courchane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Heidi Courchane from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $122.